EUVIMEDEUVIMED entdecken
Crossref

Nanoadjuvant‐Mediated Electro‐Immunotherapy Enhances Irreversible Electroporation for Pancreatic Cancer Treatment

Chengyue Zhang iD, Baohua Wang, Yacong Wang, Haojie Yu, Haoyu Liu, Wenyuan Ma, Wenjing Lou, Fan Xu, Lei Xu, Xun Zhang, Liting Xie, Xiongbin Lu und 2 weitere

Advanced Materials · 2026

DOI: 10.1002/adma.202520546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Chengyue Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, School of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Immunotherapy, Adjuvants, Immunologic, Electroporation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Development Project of the National Major Scientific Research Instrument, Key Research and Development Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy, primarily attributable to its immunosuppressive tumor microenvironment and limited responsiveness to conventional therapies. Irreversible electroporation (IRE), a non‐thermal ablation technique, holds significant promise as it preserves critical peritumoral structures and can induce immunogenic cell death. However, the immunostimulatory effects elicited by IRE are typically transient, which constrains durable therapeutic benefit. To address this limitation, we developed an electro‐responsive nanoadjuvant system (PSFC) composed of peptide‐modified, superparamagnetic iron oxide (SPIO)‐encapsulated nanoparticles engineered to synergize with IRE. Upon IRE application, the PSFC nanoparticles undergo electro‐triggered disassembly, releasing CpG oligodeoxynucleotides (CpG ODNs) to amplify both innate and adaptive immune responses. This approach promotes antigen‐presenting cells’ activation and macrophage polarization toward an M1 phenotype, while enhancing intratumoral T cell activation and pro‐inflammatory cytokine secretion. By enabling spatiotemporal control of immune activation, this combined electro‐immunotherapeutic strategy effectively overcomes the inherent immuno‐resistance of PDAC and yields significantly improved treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsImmunotherapyAdjuvants, ImmunologicElectroporationAnimalsIrreversible Electroporation TherapyCell Line, TumorOligodeoxyribonucleotidesHumansCarcinoma, Pancreatic DuctalMiceTumor MicroenvironmentPeptidesMagnetite NanoparticlesMagnetic Iron Oxide NanoparticlesT-Lymphocytes

Stichwörter der Autor:innen

electro‐immunotherapyelectro‐responsive nanoadjuvantirreversible electroporationpancreatic ductal adenocarcinomatumor microenvironment

Substanzen

Adjuvants, ImmunologicOligodeoxyribonucleotidesCPG-oligonucleotidePeptidesMagnetite Nanoparticles

Autor:innen und Institutionen

  • Department of Ultrasound, School of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
  • Department of Gerontology, School of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
  • State Key Laboratory of Chemical Engineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, China.
  • Department of Hepatobiliary and Pancreatic Surgery, School of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
  • Zhejiang Provincial Key Laboratory of Pancreatic Disease, School of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
  • MOE Joint International Research Laboratory of Pancreatic Diseases, Hangzhou, China.

ORCID-Profile: Chengyue Zhang, Tian'an Jiang

Förderung

  • National Natural Science Foundation of China
  • Development Project of the National Major Scientific Research Instrument
  • Key Research and Development Project of Zhejiang Province
  • Natural Science Foundation of Zhejiang Province
  • Medical and Health Research Project of Zhejiang Province
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, C., Wang, B., Wang, Y., Yu, H., Liu, H., Ma, W., Lou, W., Xu, F., Xu, L., Zhang, X., Xie, L., Lu, X., Zhao, Q., & Jiang, T. (2026). Nanoadjuvant‐Mediated Electro‐Immunotherapy Enhances Irreversible Electroporation for Pancreatic Cancer Treatment. Advanced Materials. https://doi.org/10.1002/adma.202520546

Vancouver

Zhang C, Wang B, Wang Y, Yu H, Liu H, Ma W, et al. Nanoadjuvant‐Mediated Electro‐Immunotherapy Enhances Irreversible Electroporation for Pancreatic Cancer Treatment. Advanced Materials. 2026. doi:10.1002/adma.202520546

BibTeX
@article{Zhang2026,
  author = {Zhang, Chengyue and Wang, Baohua and Wang, Yacong and Yu, Haojie and Liu, Haoyu and Ma, Wenyuan and Lou, Wenjing and Xu, Fan and Xu, Lei and Zhang, Xun and Xie, Liting and Lu, Xiongbin and Zhao, Qiyu and Jiang, Tian'an},
  title = {Nanoadjuvant‐Mediated Electro‐Immunotherapy Enhances Irreversible Electroporation for Pancreatic Cancer Treatment},
  journal = {Advanced Materials},
  year = {2026},
  doi = {10.1002/adma.202520546}
}
Kostenlos starten →